Paper · 37375237
Intracellular Redox Behavior of Quercetin and Resveratrol Singly and in Mixtures.
Giordano ME and 1 other. Molecules, 2023. Cited by 14 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Intracellular Redox Behavior of Quercetin and Resveratrol Singly and in Mixtures. Papers, record 37375237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37375237
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Quercetin | Major topic |
| Stilbenes | Major topic |
| Humans | |
| Resveratrol | |
| Antioxidants | |
| Reactive Oxygen Species | |
| Hydrogen Peroxide | |
| HeLa Cells | |
| Polyphenols | |
| Oxidation-Reduction |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18,789,672 | Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose. | J Nutr Biochem | 2009 | https://conductscience.org/library/papers/18789672 | PubMed |
| 2 | 2,172,711 | Flavonoids as antioxidants: determination of radical-scavenging efficiencies. | Methods Enzymol | 1990 | https://conductscience.org/library/papers/2172711 | PubMed |
| 3 | 22,650,146 | Hydroxyl radical reaction with trans-resveratrol: initial carbon radical adduct formation followed by rearrangement to phenoxyl radical. | J Phys Chem B | 2012 | https://conductscience.org/library/papers/22650146 | PubMed |
| 4 | 30,868,344 | Investigation of antioxidant activity of selenium compounds and their mixtures with tea polyphenols. | Mol Biol Rep | 2019 | https://conductscience.org/library/papers/30868344 | PubMed |
| 5 | 22,015,496 | Complex I and cytochrome c are molecular targets of flavonoids that inhibit hydrogen peroxide production by mitochondria. | Biochim Biophys Acta | 2011 | https://conductscience.org/library/papers/22015496 | PubMed |
| 6 | 27,303,304 | Intracellular Antioxidant Activity of Grape Skin Polyphenolic Extracts in Rat Superficial Colonocytes: In situ Detection by Confocal Fluorescence Microscopy. | Front Physiol | 2016 | https://conductscience.org/library/papers/27303304 | PubMed |
| 7 | 27,623,718 | New phytochemicals as potential human anti-aging compounds: Reality, promise, and challenges. | Crit Rev Food Sci Nutr | 2018 | https://conductscience.org/library/papers/27623718 | PubMed |
| 8 | 33,508,425 | 'Antioxidant' berries, anthocyanins, resveratrol and rosmarinic acid oxidize hydrogen sulfide to polysulfides and thiosulfate: A novel mechanism underlying their biological actions. | Free Radic Biol Med | 2021 | https://conductscience.org/library/papers/33508425 | PubMed |
| 9 | 26,206,193 | Pro-oxidant activity of polyphenols and its implication on cancer chemoprevention and chemotherapy. | Biochem Pharmacol | 2015 | https://conductscience.org/library/papers/26206193 | PubMed |
| 10 | 27,241,122 | Prooxidant Activity of Polyphenols, Flavonoids, Anthocyanins and Carotenoids: Updated Review of Mechanisms and Catalyzing Metals. | Phytother Res | 2016 | https://conductscience.org/library/papers/27241122 | PubMed |
1 to 10 of 57
See all 57 referencesCited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,979,040 | Naringenin in pancreatic cancer: emerging evidence on the tumor immune-stromal microenvironment, immunometabolic reprogramming, microbiota-host crosstalk, and therapeutic resistance. | Front Immunol | 2026 | https://conductscience.org/library/papers/42979040 | PubMed |
| 42,883,931 | Dual-Loaded Quercetin-Resveratrol Niosomes: Sustained In Vitro Release and Retained Bioactivity in Hummus During Simulated Gastrointestinal Digestion. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42883931 | PubMed |
| 41,897,504 | Investigating the Antioxidant and Immunomodulatory Effects of Quercetin Using Porcine PBMCs as an Inflammatory In Vitro Model. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/41897504 | PubMed |
| 41,683,519 | Advances in Plant-Sourced Natural Compounds as Anticancer Agents. | Molecules | 2026 | https://conductscience.org/library/papers/41683519 | PubMed |
| 41,639,942 | The estrogen-progestogen-oxidative stress network in uterine fibroids: mechanistic insights and therapeutic opportunities. | Redox Rep | 2026 | https://conductscience.org/library/papers/41639942 | PubMed |
| 41,011,647 | Intracellular Dual Behavior of Trolox in HeLa Cells and 3T3 Fibroblasts Under Basal and H2O2-Induced Oxidative Stress Conditions. | Molecules | 2025 | https://conductscience.org/library/papers/41011647 | PubMed |
| 40,722,883 | Paternal and/or Maternal Blackberry (Rubus spp.) Polyphenolic Extract Consumption Improved Paternal Fertility and Differentially Affected Female Offspring Antioxidant Capacity and Metabolic Programming in a Mouse Model. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40722883 | PubMed |
| 40,551,897 | Impact of polyethylene terephthalate nanoplastics (PET) on fibroblasts: a study on NIH-3T3 cells. | Front Physiol | 2025 | https://conductscience.org/library/papers/40551897 | PubMed |
| 39,596,162 | A Systematic Review: Quercetin-Secondary Metabolite of the Flavonol Class, with Multiple Health Benefits and Low Bioavailability. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39596162 | PubMed |
| 38,931,357 | Comprehensive Analysis of Novel Synergistic Antioxidant Formulations: Insights into Pharmacotechnical, Physical, Chemical, and Antioxidant Properties. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38931357 | PubMed |
1 to 10 of 12
See all 12 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MPO | 4,353 | PubTator's text mining | https://conductscience.org/library/genes/4353 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37375237
GET https://conductscience.org/api/papers/v1/37375237/references?page=2